{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T06:01:57Z","timestamp":1785391317615,"version":"3.55.0"},"reference-count":211,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T00:00:00Z","timestamp":1785369600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Viral respiratory infections are a leading cause of morbidity and mortality in children worldwide, with lower respiratory tract infections (LRTIs) a major contributor to hospitalizations and healthcare utilization. Among respiratory pathogens, respiratory syncytial virus (RSV) is the leading cause of severe disease in early life and has driven major advances in preventive strategies. Increasing evidence also suggests that early-life viral infections may influence long-term respiratory outcomes, including recurrent wheezing and asthma.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aim of the study<\/jats:title>\n                    <jats:p>This article provides a comprehensive overview of the epidemiological burden, risk factors, and long-term consequences of pediatric viral infections. It also examines RSV as a case study in the evolution of preventive strategies and explores knowledge that can be translated from RSV management to other major respiratory viruses, including influenza, SARS-CoV-2, rhinovirus, human metapneumovirus (HMPV), and parainfluenza.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>RSV has reshaped pediatric respiratory prevention through the development of monoclonal antibodies and maternal vaccination strategies, enabling a shift from high-risk-based approaches to broader population-level protection. Advances in structural virology have enabled targeting of conserved viral epitopes, thereby improving efficacy and the duration of protection. Similar strategies are being explored for other respiratory viruses. However, antigenic variability, limited pediatric data, and incomplete vaccine effectiveness remain significant barriers.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>RSV experience provides a robust foundation for preventing viral respiratory infections. Integrating passive and active immunization strategies, targeting conserved viral structures, and improving global access are essential to reduce the disease burden of pediatric respiratory infections.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fped.2026.1864969","type":"journal-article","created":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T05:39:19Z","timestamp":1785389959000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Insights Into monoclonal antibodies and vaccines targeting respiratory viruses"],"prefix":"10.3389","volume":"14","author":[{"given":"Antonella","family":"Gambadauro","sequence":"first","affiliation":[{"name":"Pediatric Unit, Department of Human Pathology in Adult and Developmental Age \u201cGaetano Barresi\u201d, University of Messina","place":["Messina, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanna A.","family":"Piedimonte","sequence":"additional","affiliation":[{"name":"Columbia College, Columbia University in the City of New York","place":["New York, NY, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Manti","sequence":"additional","affiliation":[{"name":"Pediatric Unit, Department of Human Pathology in Adult and Developmental Age \u201cGaetano Barresi\u201d, University of Messina","place":["Messina, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Piedimonte","sequence":"additional","affiliation":[{"name":"Departments of Pediatrics, Biochemistry & Molecular Biology, Tulane University","place":["New Orleans, LA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,7,30]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1016\/S0140-6736(25)01917-8","article-title":"Global burden of 292 causes of death in 204 countries and territories and 660 subnational locations, 1990\u20132023: a systematic analysis for the global burden of disease study 2023","volume":"406","author":"Naghavi","year":"2025","journal-title":"Lancet"},{"key":"B2","doi-asserted-by":"publisher","first-page":"6178","DOI":"10.3390\/ijms25116178","article-title":"Immune response to respiratory viral infections","volume":"25","author":"Gambadauro","year":"2024","journal-title":"Int J Mol Sci"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1016\/S0140-6736(24)00138-7","article-title":"Global disease burden of and risk factors for acute lower respiratory infections caused by respiratory syncytial virus in preterm infants and young children in 2019: a systematic review and meta-analysis of aggregated and individual participant data","volume":"403","author":"Wang","year":"2024","journal-title":"Lancet"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1016\/S0140-6736(24)01716-1","article-title":"Severe respiratory syncytial virus infection in children: burden, management, and emerging therapies","volume":"404","author":"Mazur","year":"2024","journal-title":"Lancet"},{"key":"B5","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/S1473-3099(25)00689-9","article-title":"Global burden of lower respiratory infections and aetiologies, 1990\u20132023: a systematic analysis for the global burden of disease study 2023","volume":"26","author":"Sirota","year":"2026","journal-title":"Lancet Infect Dis"},{"key":"B6","doi-asserted-by":"publisher","first-page":"2425","DOI":"10.1056\/NEJMoa2309189","article-title":"Nirsevimab for prevention of hospitalizations due to RSV in infants","volume":"389","author":"Drysdale","year":"2023","journal-title":"N Engl J Med"},{"key":"B7","doi-asserted-by":"publisher","first-page":"e478","DOI":"10.1093\/infdis\/jiae581","article-title":"A phase 1b\/2a trial of a half-life extended respiratory syncytial virus neutralizing antibody, clesrovimab, in healthy preterm and full-term infants","volume":"231","author":"Madhi","year":"2025","journal-title":"J Infect Dis"},{"key":"B8","doi-asserted-by":"publisher","first-page":"508","DOI":"10.15585\/mmwr.mm7432a3","article-title":"Use of clesrovimab for prevention of severe respiratory syncytial virus\u2013associated lower respiratory tract infections in infants: recommendations of the advisory committee on immunization practices\u2014United States, 2025","volume":"74","author":"Moulia","year":"2025","journal-title":"MMWR Morb Mortal Wkly Rep."},{"key":"B9","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1097\/AOG.0000000000005817","article-title":"Preterm birth frequency and associated outcomes from the MATISSE (maternal immunization study for safety and efficacy) maternal trial of the bivalent respiratory syncytial virus prefusion F protein vaccine","volume":"145","author":"Madhi","year":"2025","journal-title":"Obstet Gynecol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.15585\/mmwr.mm7241e1","article-title":"Use of the pfizer respiratory syncytial virus vaccine during pregnancy for the prevention of respiratory syncytial virus\u2013associated lower respiratory tract disease in infants: recommendations of the advisory committee on immunization practices\u2014United States, 2023","volume":"72","author":"Fleming-Dutra","year":"2023","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"B11","doi-asserted-by":"publisher","first-page":"44","DOI":"10.5409\/wjcp.v9.i3.44","article-title":"Influenza B infections in children: a review","volume":"9","author":"Bhat","year":"2020","journal-title":"World J Clin Pediatr"},{"key":"B12","doi-asserted-by":"publisher","first-page":"4638","DOI":"10.1002\/jmv.26990","article-title":"A brief review of influenza virus infection","volume":"93","author":"Javanian","year":"2021","journal-title":"J Med Virol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"101303","DOI":"10.1016\/j.lanmic.2025.101303","article-title":"Human metapneumovirus prevention within reach: advances in vaccines and monoclonal antibodies","volume":"7","author":"Li","year":"2025","journal-title":"Lancet Microbe"},{"key":"B14","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1186\/s12879-025-12513","article-title":"Shifting patterns of pediatric respiratory viruses during the SARS-CoV-2 pandemic: a retrospective observational study","volume":"26","author":"Tekinsoy","year":"2026","journal-title":"BMC Infect Dis"},{"key":"B15","doi-asserted-by":"publisher","first-page":"2100","DOI":"10.1016\/S0140-6736(24)00367-2","article-title":"Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990\u20132021: a systematic analysis for the global burden of disease study 2021","volume":"403","author":"Naghavi","year":"2024","journal-title":"Lancet"},{"key":"B16","doi-asserted-by":"publisher","first-page":"262","DOI":"10.3390\/antiox14030262","article-title":"Impact of E-cigarettes on fetal and neonatal lung development: the influence of oxidative stress and inflammation","volume":"14","author":"Gambadauro","year":"2025","journal-title":"Antioxidants"},{"key":"B17","doi-asserted-by":"publisher","first-page":"020421","DOI":"10.7189\/jogh.09.020421","article-title":"Global mortality associated with seasonal influenza epidemics: new burden estimates and predictors from the GLaMOR project","volume":"9","author":"Paget","year":"2019","journal-title":"J Glob Health"},{"key":"B18","doi-asserted-by":"publisher","first-page":"e15352","DOI":"10.15252\/emmm.202115352","article-title":"Seasonality of influenza and other respiratory viruses","volume":"14","author":"Neumann","year":"2022","journal-title":"EMBO Mol Med"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1093\/infdis\/jiy056","article-title":"Respiratory syncytial virus seasonality: a global overview","volume":"217","author":"Obando-Pacheco","year":"2018","journal-title":"J Infect Dis"},{"key":"B20","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1289\/ehp.1002383","article-title":"Global influenza seasonality: reconciling patterns across temperate and tropical regions","volume":"119","author":"Tamerius","year":"2011","journal-title":"Environ Health Perspect"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1086\/507638","article-title":"Seasonal trends of human parainfluenza viral infections: united States, 1990\u20132004","volume":"43","author":"Fry","year":"2006","journal-title":"Clin Infect Dis"},{"key":"B22","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1038\/s41598-018-37481-y","article-title":"Association between viral seasonality and meteorological factors","volume":"9","author":"Price","year":"2019","journal-title":"Sci Rep"},{"key":"B23","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1186\/s12985-022-01875-2","article-title":"Seasonal epidemiological and clinical characteristics of pediatric patients with human parainfluenza virus infection by serotype: a retrospective study","volume":"19","author":"Han","year":"2022","journal-title":"Virol J"},{"key":"B24","doi-asserted-by":"publisher","first-page":"2576","DOI":"10.3390\/diagnostics13152576","article-title":"Human parainfluenza virus (HPIV) detection in hospitalized children with acute respiratory tract infection in the Western Cape, South Africa during 2014\u20132022 reveals a shift in dominance of HPIV 3 and 4 infections","volume":"13","author":"Parsons","year":"2023","journal-title":"Diagnostics"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.3390\/v17081073","article-title":"Predictive factors and clinical markers of recurrent wheezing and asthma after RSV infection","volume":"17","author":"Buttarelli","year":"2025","journal-title":"Viruses"},{"key":"B26","doi-asserted-by":"publisher","first-page":"107125","DOI":"10.1016\/j.ijid.2024.107125","article-title":"Risk factors for respiratory syncytial virus-associated acute lower respiratory infection in children under 5 years: an updated systematic review and meta-analysis","volume":"146","author":"Deng","year":"2024","journal-title":"Int J Infect Dis"},{"key":"B27","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1186\/s12887-020-02186-7","article-title":"Hospitalizations for viral respiratory infections in children under 2 years of age: epidemiology and in-hospital complications","volume":"20","author":"Zurita-Cruz","year":"2020","journal-title":"BMC Pediatr"},{"key":"B28","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.1017\/S1047951117000609","article-title":"CHD And respiratory syncytial virus: global expert exchange recommendations","volume":"27","author":"Tulloh","year":"2017","journal-title":"Cardiol Young"},{"key":"B29","doi-asserted-by":"publisher","first-page":"e0172512","DOI":"10.1371\/journal.pone.0172512","article-title":"Respiratory syncytial virus hospitalization risk in the second year of life by specific congenital heart disease diagnoses","volume":"12","author":"Friedman","year":"2017","journal-title":"PLoS One"},{"key":"B30","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1097\/INF.0000000000004258","article-title":"Risk factors for poor outcomes in children hospitalized with virus-associated acute lower respiratory infections: a systematic review and meta-analysis","volume":"43","author":"Trusinska","year":"2024","journal-title":"Pediatr Infect Dis J"},{"key":"B31","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1093\/oxfordjournals.aje.a121550","article-title":"Epidemiology of respiratory syncytial virus infection in Washington, D.C","volume":"98","author":"Kim","year":"1973","journal-title":"Am J Epidemiol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1056\/NEJMoa025472","article-title":"Human metapneumovirus and lower respiratory tract disease in otherwise healthy infants and children","volume":"350","author":"Williams","year":"2004","journal-title":"N Engl J Med"},{"key":"B33","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1086\/511821","article-title":"Rhinovirus-associated hospitalizations in young children","volume":"195","author":"Miller","year":"2007","journal-title":"J Infect Dis"},{"key":"B34","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1097\/01.inf.0000143642.72480.53","article-title":"Rhinovirus-associated wheezing in infancy","volume":"23","author":"Korppi","year":"2004","journal-title":"Pediatr Infect Dis J"},{"key":"B35","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1097\/INF.0b013e31812e52e6","article-title":"Role of rhinovirus in hospitalized infants with respiratory tract infections in Spain","volume":"26","author":"Calvo","year":"2007","journal-title":"Pediatr Infect Dis J"},{"key":"B36","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.3201\/eid1006.030629","article-title":"Respiratory picornaviruses and respiratory syncytial virus as causative agents of acute expiratory wheezing in children","volume":"10","author":"Jartti","year":"2004","journal-title":"Emerg Infect Dis"},{"key":"B37","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1016\/S0140-6736(98)10321-5","article-title":"Respiratory syncytial virus in early life and risk of wheeze and allergy by age 13 years","volume":"354","author":"Stein","year":"1999","journal-title":"Lancet"},{"key":"B38","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1097\/01.inf.0000122604.32137.29","article-title":"Impact of wheezing after respiratory syncytial virus infection on health-related quality of life","volume":"23","author":"Bont","year":"2004","journal-title":"Pediatr Infect Dis J"},{"key":"B39","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1164\/rccm.200406-730OC","article-title":"Severe respiratory syncytial virus bronchiolitis in infancy and asthma and allergy at age 13","volume":"171","author":"Sigurs","year":"2005","journal-title":"Am J Respir Crit Care Med"},{"key":"B40","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.1136\/bmj.284.6330.1665","article-title":"Wheezing, asthma, and pulmonary dysfunction 10 years after infection with respiratory syncytial virus in infancy","volume":"284","author":"Pullan","year":"1982","journal-title":"Br Med J"},{"key":"B41","doi-asserted-by":"publisher","first-page":"e0265094","DOI":"10.1371\/journal.pone.0265094","article-title":"RSV-induced changes in a 3- dimensional organoid model of human fetal lungs","volume":"17","author":"Harford","year":"2022","journal-title":"PLoS One"},{"key":"B42","doi-asserted-by":"publisher","first-page":"10234","DOI":"10.3390\/ijms251910234","article-title":"Update on the role of \u03b22AR and TRPV1 in respiratory diseases","volume":"25","author":"Manti","year":"2024","journal-title":"Int J Mol Sci"},{"key":"B43","doi-asserted-by":"publisher","first-page":"e0171681","DOI":"10.1371\/journal.pone.0171681","article-title":"Respiratory virus infection up-regulates TRPV1, TRPA1 and ASICS3 receptors on airway cells","volume":"12","author":"Omar","year":"2017","journal-title":"PLoS One"},{"key":"B44","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1016\/j.jaci.2017.07.015","article-title":"Asthma predisposition and respiratory syncytial virus infection modulate transient receptor potential vanilloid 1 function in children\u2019s airways","volume":"141","author":"Harford","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"B45","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1164\/ajrccm.159.3.9801052","article-title":"Rhinovirus and respiratory syncytial virus in wheezing children requiring emergency care","volume":"159","author":"Rakes","year":"1999","journal-title":"Am J Respir Crit Care Med."},{"key":"B46","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1016\/j.jaci.2005.06.024","article-title":"Rhinovirus illnesses during infancy predict subsequent childhood wheezing","volume":"116","author":"Lemanske","year":"2005","journal-title":"J Allergy Clin Immunol"},{"key":"B47","doi-asserted-by":"publisher","first-page":"2894","DOI":"10.4049\/jimmunol.1101391","article-title":"Neonatal rhinovirus infection induces mucous metaplasia and airways hyperresponsiveness","volume":"188","author":"Schneider","year":"2012","journal-title":"J Immunol"},{"key":"B48","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.4049\/jimmunol.179.2.1080","article-title":"TLR3- and Th2 cytokine-dependent production of thymic stromal lymphopoietin in human airway epithelial cells","volume":"179","author":"Kato","year":"2007","journal-title":"J Immunol"},{"key":"B49","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1111\/all.12329","article-title":"Inhaled ds RNA and rhinovirus evoke neutrophilic exacerbation and lung expression of thymic stromal lymphopoietin in allergic mice with established experimental asthma","volume":"69","author":"Mahmutovic-Persson","year":"2014","journal-title":"Allergy"},{"key":"B50","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.jaci.2018.02.008","article-title":"Recurrent wheezing in children following human metapneumovirus infection","volume":"142","author":"Coverstone","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"B51","doi-asserted-by":"publisher","first-page":"00832","DOI":"10.1183\/23120541.00832-2023","article-title":"Bronchial reactivity and asthma at school age after early-life metapneumovirus infection","volume":"10","author":"Myklebust","year":"2024","journal-title":"ERJ Open Res"},{"key":"B52","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1080\/21505594.2016.1265725","article-title":"Aberrant T cell immunity triggered by human respiratory syncytial virus and human metapneumovirus infection","volume":"8","author":"Gonz\u00e1lez","year":"2017","journal-title":"Virulence"},{"key":"B53","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1126\/science.1243283","article-title":"Structure-Based design of a fusion glycoprotein vaccine for respiratory syncytial virus","volume":"342","author":"McLellan","year":"2013","journal-title":"Science (1979)"},{"key":"B54","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1186\/s12931-016-0474-9","article-title":"Respiratory viral infections and host responses; insights from genomics","volume":"17","author":"Troy","year":"2016","journal-title":"Respir Res"},{"key":"B55","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.1056\/NEJM200106213442507","article-title":"Respiratory syncytial virus and parainfluenza virus","volume":"344","author":"Hall","year":"2001","journal-title":"N Engl J Med"},{"key":"B56","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1007\/s40121-024-01012-2","article-title":"Differences between RSV A and RSV B subgroups and implications for pharmaceutical preventive measures","volume":"13","author":"Nuttens","year":"2024","journal-title":"Infect Dis Ther"},{"key":"B57","doi-asserted-by":"publisher","first-page":"998296","DOI":"10.3389\/fped.2022.998296","article-title":"An overview on the RSV-mediated mechanisms in the onset of non-allergic asthma","volume":"10","author":"Manti","year":"2022","journal-title":"Front Pediatr"},{"key":"B58","doi-asserted-by":"publisher","first-page":"e1007984","DOI":"10.1371\/journal.ppat.1007984","article-title":"Respiratory syncytial virus nonstructural proteins 1 and 2: exceptional disrupters of innate immune responses","volume":"15","author":"Sedeyn","year":"2019","journal-title":"PLoS Pathog"},{"key":"B59","doi-asserted-by":"publisher","first-page":"2478","DOI":"10.3390\/v13122478","article-title":"Immunopathology of RSV: an updated review","volume":"13","author":"Bergeron","year":"2021","journal-title":"Viruses"},{"key":"B60","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1128\/CVI.00590-15","article-title":"Mucosal IgG levels correlate better with respiratory syncytial virus load and inflammation than plasma IgG levels","volume":"23","author":"Vissers","year":"2016","journal-title":"Clin Vaccine Immunol"},{"key":"B61","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1128\/CMR.00090-16","article-title":"The human immune response to respiratory syncytial virus infection","volume":"30","author":"Russell","year":"2017","journal-title":"Clin Microbiol Rev"},{"key":"B62","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1016\/S2213-2600(15)00255-6","article-title":"Lower respiratory tract infection caused by respiratory syncytial virus: current management and new therapeutics","volume":"3","author":"Mazur","year":"2015","journal-title":"Lancet Respir Med"},{"key":"B63","doi-asserted-by":"publisher","first-page":"594898","DOI":"10.3389\/fped.2020.594898","article-title":"Respiratory syncytial virus bronchiolitis in infancy: the acute hospitalization cost","volume":"8","author":"Bozzola","year":"2021","journal-title":"Front Pediatr."},{"key":"B64","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s13052-022-01392-6","article-title":"UPDATE \u2013 2022 Italian guidelines on the management of bronchiolitis in infants","volume":"49","author":"Manti","year":"2023","journal-title":"Ital J Pediatr."},{"key":"B65","year":"2019"},{"key":"B66","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1542\/peds.72.5.613","article-title":"Ribavirin aerosol treatment of bronchiolitis associated with respiratory syncytial virus infection in infants","volume":"72","author":"Taber","year":"1983","journal-title":"Pediatrics"},{"key":"B67","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1056\/NEJM198306163082403","article-title":"Aerosolized ribavirin treatment of infants with respiratory syncytial viral infection","volume":"308","author":"Hall","year":"1983","journal-title":"N Engl J Med"},{"key":"B68","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1001\/archpedi.1996.02170340056011","article-title":"Ribavirin for respiratory syncytial virus lower respiratory tract infection","volume":"150","author":"Randolph","year":"1996","journal-title":"Arch Pediatr Adolesc Med"},{"key":"B69","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/0041-008X(80)90252-5","article-title":"Embryotoxic, teratogenic, and metabolic effects of ribavirin in mice","volume":"52","author":"Kochhar","year":"1980","journal-title":"Toxicol Appl Pharmacol."},{"key":"B70","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1080\/2314808X.2023.2217650","article-title":"Investigation of the embryo-toxicity of the antiviral drug \u201cribavirin\u201d in wistar rats during different gestation periods","volume":"10","author":"Magdy","year":"2023","journal-title":"Egypt J Basic Appl Sci"},{"key":"B71","doi-asserted-by":"publisher","first-page":"372","DOI":"10.5863\/1551-6776-23.5.372","article-title":"Pediatric antiviral stewardship: defining the potential role of ribavirin in respiratory syncytial virus\u2013associated lower respiratory illness","volume":"23","author":"Hoover","year":"2018","journal-title":"J Pediatr Pharmacol Ther"},{"key":"B72","doi-asserted-by":"publisher","first-page":"101477","DOI":"10.1016\/j.coviro.2025.101477","article-title":"Status of advanced respiratory syncytial virus antiviral therapeutics 2025","volume":"73","author":"Ruckel","year":"2025","journal-title":"Curr Opin Virol"},{"key":"B73","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1056\/NEJMoa2313551","article-title":"Ziresovir in hospitalized infants with respiratory syncytial virus infection","volume":"391","author":"Zhao","year":"2024","journal-title":"N Engl J Med"},{"key":"B74","doi-asserted-by":"publisher","first-page":"e00737-17","DOI":"10.1128\/AAC.00737-17","article-title":"Preclinical characterization of PC786, an inhaled small-molecule respiratory syncytial virus L protein polymerase inhibitor","volume":"61","author":"Coates","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"B75","doi-asserted-by":"publisher","first-page":"105907","DOI":"10.1016\/j.antiviral.2024.105907","article-title":"JNJ-7184, a respiratory syncytial virus inhibitor targeting the connector domain of the viral polymerase","volume":"227","author":"Bonneux","year":"2024","journal-title":"Antiviral Res"},{"key":"B76","doi-asserted-by":"publisher","first-page":"1734","DOI":"10.1099\/vir.0.053025-0","article-title":"The respiratory syncytial virus nucleoprotein\u2013RNA complex forms a left-handed helical nucleocapsid","volume":"94","author":"Bakker","year":"2013","journal-title":"J Gen Virol"},{"key":"B77","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1093\/oxfordjournals.aje.a120954","article-title":"An epidemiologic study of altered clinical reactivity to respiratory syncytial (RS) virus infection in children previously vaccinated with an inactivated RS virus vaccine","volume":"89","author":"Kapikian","year":"1969","journal-title":"Am J Epidemiol"},{"key":"B78","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1093\/oxfordjournals.aje.a120956","article-title":"Respiratory virus immunization","volume":"89","author":"Fulginiti","year":"1969","journal-title":"Am J Epidemiol."},{"key":"B79","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1093\/oxfordjournals.aje.a120955","article-title":"Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine12","volume":"89","author":"Kim","year":"1969","journal-title":"Am J Epidemiol"},{"key":"B80","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1128\/jcm.24.2.197-202.1986","article-title":"Dissociation between serum neutralizing and glycoprotein antibody responses of infants and children who received inactivated respiratory syncytial virus vaccine","volume":"24","author":"Murphy","year":"1986","journal-title":"J Clin Microbiol"},{"key":"B81","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.4049\/jimmunol.151.4.2032","article-title":"Priming immunization determines T helper cytokine mRNA expression patterns in lungs of mice challenged with respiratory syncytial virus","volume":"151","author":"Graham","year":"1993","journal-title":"J Immunol"},{"key":"B82","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1007\/s12026-007-0071-6","article-title":"Understanding respiratory syncytial virus (RSV) vaccine-enhanced disease","volume":"39","author":"Castilow","year":"2007","journal-title":"Immunol Res"},{"key":"B83","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1146\/annurev-med-061323-073934","article-title":"New approaches to respiratory syncytial virus prevention and treatment","volume":"76","author":"Walter","year":"2025","journal-title":"Annu Rev Med"},{"key":"B84","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1056\/NEJM199311183292102","article-title":"Prophylactic administration of respiratory syncytial virus immune globulin to high-risk infants and young children","volume":"329","author":"Groothuis","year":"1993","journal-title":"N Engl J Med"},{"key":"B85","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1542\/peds.99.3.454","article-title":"Respiratory syncytial virus (RSV) immune globulin intravenous therapy for RSV lower respiratory tract infection in infants and young children at high risk for severe RSV infections","volume":"99","author":"Rodriguez","year":"1997","journal-title":"Pediatrics"},{"key":"B86","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1016\/S0022-3476(98)70056-3","article-title":"Respiratory syncytial virus immune globulin for prophylaxis against respiratory syncytial virus disease in infants and children with congenital heart disease","volume":"133","author":"Simoes","year":"1998","journal-title":"J Pediatr."},{"key":"B87","doi-asserted-by":"publisher","first-page":"e620","DOI":"10.1542\/peds.2014-1666","article-title":"Updated guidance for palivizumab prophylaxis among infants and young children at increased risk of hospitalization for respiratory syncytial virus infection","volume":"134","author":"Brady","year":"2014","journal-title":"Pediatrics"},{"key":"B88","doi-asserted-by":"publisher","first-page":"e2025073923","DOI":"10.1542\/peds.2025-073923","article-title":"Recommendations for the prevention of RSV disease in infants and children: policy statement","volume":"156","year":"2025","journal-title":"Pediatrics"},{"key":"B89","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1186\/s13052-015-0203-x","article-title":"Revised recommendations concerning palivizumab prophylaxis for respiratory syncytial virus (RSV)","volume":"41","author":"Bollani","year":"2015","journal-title":"Ital J Pediatr"},{"key":"B90","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1186\/s13052-021-01148-8","article-title":"Epidemiology and prevention of respiratory syncytial virus infections in children in Italy","volume":"47","author":"Azzari","year":"2021","journal-title":"Ital J Pediatr"},{"key":"B91","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.1056\/NEJMoa1211917","article-title":"Respiratory syncytial virus and recurrent wheeze in healthy preterm infants","volume":"368","author":"Blanken","year":"2013","journal-title":"N Engl J Med"},{"key":"B92","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1542\/peds.2013-0982","article-title":"Effect of palivizumab prophylaxis on subsequent recurrent wheezing in preterm infants","volume":"132","author":"Yoshihara","year":"2013","journal-title":"Pediatrics"},{"key":"B93","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/j.jaci.2010.05.026","article-title":"The effect of respiratory syncytial virus on subsequent recurrent wheezing in atopic and nonatopic children","volume":"126","author":"Sim\u00f5es","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"B94","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1164\/rccm.201609-1812OC","article-title":"Palivizumab prophylaxis in preterm infants and subsequent recurrent wheezing. Six-year follow-up study","volume":"196","author":"Mochizuki","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"key":"B95","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1002\/ppul.26824","article-title":"Palivizumabprophylaxis in preterm infants and subsequent wheezing\/asthma: 10-year follow-up study","volume":"59","author":"Kato","year":"2024","journal-title":"Pediatr Pulmonol"},{"key":"B96","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/s40121-017-0151-4","article-title":"The burden and long-term respiratory morbidity associated with respiratory syncytial virus infection in early childhood","volume":"6","author":"Fauroux","year":"2017","journal-title":"Infect Dis Ther."},{"key":"B97","year":""},{"key":"B98","year":""},{"key":"B99","year":""},{"key":"B100","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1056\/NEJMoa2110275","article-title":"Nirsevimab for prevention of RSV in healthy late-preterm and term infants","volume":"386","author":"Hammitt","year":"2022","journal-title":"N Engl J Med"},{"key":"B101","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1056\/NEJMc2112186","article-title":"Safety of Nirsevimab for RSV in infants with heart or lung disease or prematurity","volume":"386","author":"Domachowske","year":"2022","journal-title":"N Engl J Med"},{"key":"B102","year":""},{"key":"B103","doi-asserted-by":"publisher","first-page":"920","DOI":"10.15585\/mmwr.mm7234a4","article-title":"Use of nirsevimab for the prevention of respiratory syncytial virus disease among infants and young children: recommendations of the advisory committee on immunization practices\u2014United States, 2023","volume":"72","author":"Jones","year":"2023","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"B104","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s44250-025-00198-7","article-title":"Lessons from implementing a long-acting monoclonal antibody (nirsevimab) for RSV in France, Spain and the US","volume":"4","author":"Morris","year":"2025","journal-title":"Discover Health Systems"},{"key":"B105","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s13052-025-01844-9","article-title":"Learn from international recommendations and experiences of countries that have successfully implemented monoclonal antibody prophylaxis for prevention of RSV infection","volume":"51","author":"Manti","year":"2025","journal-title":"Ital J Pediatr"},{"key":"B106","doi-asserted-by":"publisher","first-page":"503","DOI":"10.3390\/pathogens13060503","article-title":"Comprehensive summary of safety data on nirsevimab in infants and children from all pivotal randomized clinical trials","volume":"13","author":"Mankad","year":"2024","journal-title":"Pathogens"},{"key":"B107","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1038\/s41390-024-03782-4","article-title":"Nirsevimab decreased the subsequent risk of respiratory syncytial virus infection and wheezing in the 2023\u20132024 RSV season","volume":"98","author":"Ma","year":"2025","journal-title":"Pediatr Res."},{"key":"B108","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1001\/jama.2025.10319","article-title":"FDA Approves new RSV monoclonal antibody to protect infants","volume":"334","author":"Anderer","year":"2025","journal-title":"JAMA"},{"key":"B109","volume-title":"Integrated review of clesrovimab application","year":"2025"},{"key":"B110","year":""},{"key":"B111","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1056\/NEJMc2506107","article-title":"Clesrovimab in infants and children at increased risk for severe RSV disease","volume":"393","author":"Zar","year":"2025","journal-title":"N Engl J Med"},{"key":"B112","doi-asserted-by":"publisher","first-page":"107995","DOI":"10.1016\/j.cct.2025.107995","article-title":"Evaluation of a monoclonal antibody against respiratory syncytial virus, clesrovimab, in infants and children: comprehensive rationale and study design for the late-stage clinical trials","volume":"157","author":"Sinha","year":"2025","journal-title":"Contemp Clin Trials"},{"key":"B113","doi-asserted-by":"publisher","first-page":"e4400","DOI":"10.1093\/cid\/ciaa951","article-title":"Suptavumab for the prevention of medically attended respiratory syncytial virus infection in preterm infants","volume":"73","author":"Sim\u00f5es","year":"2021","journal-title":"Clin Infect Dis"},{"key":"B114","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.anai.2020.03.017","article-title":"The journey to a respiratory syncytial virus vaccine","volume":"125","author":"Mejias","year":"2020","journal-title":"Ann Allergy Asthma Immunol"},{"key":"B115","doi-asserted-by":"publisher","first-page":"e97521","DOI":"10.7759\/cureus.97521","article-title":"The evolving landscape of respiratory syncytial virus (RSV) prophylaxis in infants","volume":"17","author":"Chamarthi","year":"2025","journal-title":"Cureus"},{"key":"B116","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1097\/00006454-199601000-00006","article-title":"Purified fusion protein vaccine protects against lower respiratory tract illness during respiratory syncytial virus season in children with cystic fibrosis","volume":"15","author":"Piedra","year":"1996","journal-title":"Pediatr Infect Dis J"},{"key":"B117","doi-asserted-by":"publisher","first-page":"2448","DOI":"10.1016\/S0264-410X(03)00098-7","article-title":"Immunogenicity of a new purified fusion protein vaccine to respiratory syncytial virus: a multi-center trial in children with cystic fibrosis","volume":"21","author":"Piedra","year":"2003","journal-title":"Vaccine"},{"key":"B118","doi-asserted-by":"publisher","first-page":"S94","DOI":"10.1097\/01.inf.0000053893.15894.ff","article-title":"Clinical experience with respiratory syncytial virus vaccines","volume":"22","author":"Piedra","year":"2003","journal-title":"Pediatr Infect Dis J"},{"key":"B119","doi-asserted-by":"publisher","first-page":"3465","DOI":"10.1016\/S0264-410X(03)00352-9","article-title":"Safety and immunogenicity of respiratory syncytial virus purified fusion protein-2 vaccine in pregnant women","volume":"21","author":"Munoz","year":"2003","journal-title":"Vaccine"},{"key":"B120","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1164\/rccm.202005-1660OC","article-title":"Live-Attenuated vaccines prevent respiratory syncytial virus\u2013associated illness in young children","volume":"203","author":"Karron","year":"2021","journal-title":"Am J Respir Crit Care Med"},{"key":"B121","first-page":"259","volume-title":"Live-Attenuated Respiratory Syncytial Virus Vaccines","author":"Karron","year":"2013"},{"key":"B122","doi-asserted-by":"publisher","first-page":"582","DOI":"10.4161\/hv.9131","article-title":"Challenges in developing a pediatric RSV vaccine","volume":"5","author":"Schickli","year":"2009","journal-title":"Hum Vaccin"},{"key":"B123","doi-asserted-by":"publisher","first-page":"e295","DOI":"10.1016\/S1473-3099(18)30292-5","article-title":"The respiratory syncytial virus vaccine landscape: lessons from the graveyard and promising candidates","volume":"18","author":"Mazur","year":"2018","journal-title":"Lancet Infect Dis"},{"key":"B124","doi-asserted-by":"publisher","first-page":"2050","DOI":"10.1093\/infdis\/jiaa049","article-title":"Live-Attenuated respiratory syncytial virus vaccine with M2-2 deletion and with small hydrophobic noncoding region is highly immunogenic in children","volume":"221","author":"McFarland","year":"2020","journal-title":"J Infect Dis"},{"key":"B125","year":"2024"},{"key":"B126","year":"2024"},{"key":"B127","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1093\/infdis\/jiad281","article-title":"Evaluation of the live-attenuated intranasal respiratory syncytial virus (RSV) vaccine RSV\/6120\/\u0394NS2\/1030s in RSV-seronegative young children","volume":"229","author":"Karron","year":"2024","journal-title":"J Infect Dis"},{"key":"B128","doi-asserted-by":"publisher","first-page":"CD016131","DOI":"10.1002\/14651858.CD016131","article-title":"Efficacy and safety of respiratory syncytial virus vaccines","volume":"2025","author":"Saif-Ur-Rahman","year":"2025","journal-title":"Cochrane Database Syst Rev"},{"key":"B129","doi-asserted-by":"publisher","first-page":"2557676","DOI":"10.1080\/21645515.2025.2557676","article-title":"Safety and immunogenicity of an mRNA-based RSV vaccine in seropositive children aged 12\u201359 months","volume":"21","author":"Schnyder Ghamloush","year":"2025","journal-title":"Hum Vaccin Immunother"},{"key":"B130","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1093\/infdis\/jiz408","article-title":"Safety and immunogenicity of the respiratory syncytial virus vaccine RSV\/\u0394NS2\/\u03941313\/I1314L in RSV-seronegative children","volume":"222","author":"Karron","year":"2020","journal-title":"J Infect Dis"},{"key":"B131","doi-asserted-by":"publisher","first-page":"EVIDoa2500026","DOI":"10.1056\/EVIDoa2500026","article-title":"Live-Attenuated intranasal RSV vaccine in infants and toddlers","volume":"4","author":"Idoko","year":"2025","journal-title":"NEJM Evidence"},{"key":"B132","year":"2023"},{"key":"B133","year":"2024"},{"key":"B134","doi-asserted-by":"publisher","first-page":"ofae453","DOI":"10.1093\/ofid\/ofae453","article-title":"A phase 1\/2a study evaluating safety and immunogenicity of Ad26.RSV.preF in RSV-seronegative toddlers aged 12\u201324 months","volume":"11","author":"Langley","year":"2024","journal-title":"Open Forum Infect Dis"},{"key":"B135","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1056\/NEJMoa2216480","article-title":"Bivalent prefusion F vaccine in pregnancy to prevent RSV illness in infants","volume":"388","author":"Kampmann","year":"2023","journal-title":"N Engl J Med"},{"key":"B136","article-title":"Protection Against Infant Illness with a Bivalent RSVpreV Vaccine in Pregnancy: Final Analysis","author":"Kampmann","year":"2024"},{"key":"B137","doi-asserted-by":"publisher","first-page":"e1004625","DOI":"10.1371\/journal.pmed.1004625","article-title":"The benefits and risks of maternal RSV vaccination on mortality in South Africa: a modeling study","volume":"23","author":"Monoi","year":"2026","journal-title":"PLoS Med"},{"key":"B138","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1016\/S0140-6736(24)01699-4","article-title":"Respiratory syncytial virus vaccination and immunoprophylaxis: realising the potential for protection of young children","volume":"404","author":"Pecenka","year":"2024","journal-title":"Lancet"},{"key":"B139","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1016\/S2352-4642(26)00075-1","article-title":"Effectiveness of nirsevimab immunisation after birth versus RSVpreF maternal vaccination in preventing RSV-related hospitalisations in infants: a population based retrospective cohort study","volume":"10","author":"Valtuille","year":"2026","journal-title":"Lancet Child Adolesc Health"},{"key":"B140","doi-asserted-by":"publisher","first-page":"4554","DOI":"10.1038\/s41598-020-79590-7","article-title":"Next generation methodology for updating HA vaccines against emerging human seasonal influenza A(H3N2) viruses","volume":"11","author":"Allen","year":"2021","journal-title":"Sci Rep"},{"key":"B141","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1111\/irv.12470","article-title":"The hidden burden of influenza: a review of the extra-pulmonary complications of influenza infection","volume":"11","author":"Sellers","year":"2017","journal-title":"Influenza Other Respir Viruses"},{"key":"B142","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.amjmed.2007.10.040","article-title":"Complications of viral influenza","volume":"121","author":"Rothberg","year":"2008","journal-title":"Am J Med"},{"key":"B143","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1001\/archpedi.156.10.986","article-title":"Illness among schoolchildren during influenza season","volume":"156","author":"Neuzil","year":"2002","journal-title":"Arch Pediatr Adolesc Med"},{"key":"B144","doi-asserted-by":"publisher","first-page":"e75339","DOI":"10.1371\/journal.pone.0075339","article-title":"Influenza transmission in a cohort of households with children: 2010\u20132011","volume":"8","author":"Petrie","year":"2013","journal-title":"PLoS One"},{"key":"B145","doi-asserted-by":"publisher","first-page":"e01914","DOI":"10.7554\/eLife.01914","article-title":"Integrating influenza antigenic dynamics with molecular evolution","volume":"3","author":"Bedford","year":"2014","journal-title":"Elife"},{"key":"B146","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1001\/jama.2010.250","article-title":"Effect of influenza vaccination of children on infection rates in hutterite communities","volume":"303","author":"Loeb","year":"2010","journal-title":"JAMA"},{"key":"B147","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1093\/cid\/ciu340","article-title":"School-Located influenza vaccination decreases laboratory-confirmed influenza and improves school attendance","volume":"59","author":"Pannaraj","year":"2014","journal-title":"Clin Infect Dis"},{"key":"B148","year":"2026"},{"key":"B149","doi-asserted-by":"publisher","first-page":"e2025073620","DOI":"10.1542\/peds.2025-073620","article-title":"Recommendations for prevention and control of influenza in children, 2025\u20132026: policy statement","volume":"156","author":"O\u2019Leary","year":"2025","journal-title":"Pediatrics"},{"key":"B150","doi-asserted-by":"publisher","first-page":"e2025073622","DOI":"10.1542\/peds.2025-073622","article-title":"Recommendations for prevention and control of influenza in children, 2025\u20132026: technical report","volume":"156","author":"O\u2019Leary","year":"2025","journal-title":"Pediatrics"},{"key":"B151","doi-asserted-by":"publisher","first-page":"116","DOI":"10.15585\/mmwr.mm7509a2","article-title":"Interim estimates of 2025\u201326 seasonal influenza vaccine effectiveness\u2014United States, September 2025\u2013February 2026","volume":"75","author":"Maloney","year":"2026","journal-title":"MMWR Morb Mortal Wkly Rep."},{"key":"B152","doi-asserted-by":"publisher","first-page":"1669073","DOI":"10.3389\/fimmu.2025.1669073","article-title":"Monoclonal antibodies against influenza viruses: a clinical trials review","volume":"16","author":"Mota","year":"2025","journal-title":"Front Immunol"},{"key":"B153","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1084\/jem.20101352","article-title":"Broadly cross-reactive antibodies dominate the human B cell response against 2009 pandemic H1N1 influenza virus infection","volume":"208","author":"Wrammert","year":"2011","journal-title":"J Exp Med"},{"key":"B154","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1111\/irv.12446","article-title":"Influenza antivirals currently in late-phase clinical trial","volume":"11","author":"Koszalka","year":"2017","journal-title":"Influenza Other Respir Viruses"},{"key":"B155","doi-asserted-by":"publisher","first-page":"e80034","DOI":"10.1371\/journal.pone.0080034","article-title":"Mechanisms of hemagglutinin targeted influenza virus neutralization","volume":"8","author":"Brandenburg","year":"2013","journal-title":"PLoS One"},{"key":"B156","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1056\/NEJMra050740","article-title":"Neuraminidase inhibitors for influenza","volume":"353","author":"Moscona","year":"2005","journal-title":"N Engl J Med"},{"key":"B157","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1038\/s41573-019-0056-x","article-title":"Next-generation influenza vaccines: opportunities and challenges","volume":"19","author":"Wei","year":"2020","journal-title":"Nat Rev Drug Discov"},{"key":"B158","doi-asserted-by":"publisher","first-page":"2144","DOI":"10.1016\/S0140-6736(12)61690-0","article-title":"Healthy life expectancy for 187 countries, 1990\u20132010: a systematic analysis for the global burden disease study 2010","volume":"380","author":"Salomon","year":"2012","journal-title":"Lancet"},{"key":"B159","doi-asserted-by":"publisher","first-page":"1738181","DOI":"10.3389\/fmicb.2025.1738181","article-title":"Broadly neutralizing monoclonal antibodies against influenza A viruses: current insights and future directions","volume":"16","author":"Mahrous","year":"2026","journal-title":"Front Microbiol"},{"key":"B160","doi-asserted-by":"publisher","first-page":"126808","DOI":"10.1016\/j.vaccine.2025.126808","article-title":"Estimating COVID-19 associated hospitalizations, ICU admissions, and in-hospital deaths averted in the United States by 2023\u20132024 COVID-19 vaccination: a conditional probability, causal inference, and multiplier-based approach","volume":"49","author":"Wiegand","year":"2025","journal-title":"Vaccine"},{"key":"B161","doi-asserted-by":"publisher","first-page":"12910","DOI":"10.1074\/jbc.REV120.013930","article-title":"The molecular virology of coronaviruses","volume":"295","author":"Hartenian","year":"2020","journal-title":"J Biol Chem"},{"key":"B162","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1002\/ppul.25344","article-title":"COVID-19 in childhood: transmission, clinical presentation, complications and risk factors","volume":"56","author":"Siebach","year":"2021","journal-title":"Pediatr Pulmonol"},{"key":"B163","doi-asserted-by":"publisher","first-page":"e2025073924","DOI":"10.1542\/peds.2025-073924","article-title":"Recommendations for COVID-19 vaccines in infants, children, and adolescents: policy statement","volume":"156","year":"2025","journal-title":"Pediatrics"},{"key":"B164","volume-title":"Immunization, Vaccines and Biological","year":"2025"},{"key":"B165","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1097\/EDE.0000000000001908","article-title":"OpenSAFELY: effectiveness of COVID-19 vaccination in children and adolescents","volume":"37","author":"Andrews","year":"2026","journal-title":"Epidemiology"},{"key":"B166","doi-asserted-by":"publisher","first-page":"ofac080","DOI":"10.1093\/ofid\/ofac080","article-title":"Comparative efficacy of early COVID-19 monoclonal antibody therapies: a retrospective analysis","volume":"9","author":"San Filippo","year":"2022","journal-title":"Open Forum Infect Dis"},{"key":"B167","volume-title":"SRBTIFL. StatPearls [Serial Online]","author":"Shrestha","year":"2023"},{"key":"B168","author":"Agency","year":"2021"},{"key":"B169","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1097\/INF.0000000000003773","article-title":"Treatment of infants and children with SARS-CoV-2 monoclonal antibodies: a European case series","volume":"42","author":"Rau","year":"2023","journal-title":"Pediatr Infect Dis J"},{"key":"B170","author":"Balasundaram","year":"2026"},{"key":"B171","volume-title":"FDA Updates Sotrovimab Emergency Use Authorization","year":"2022"},{"key":"B172","doi-asserted-by":"publisher","first-page":"e2254909","DOI":"10.1001\/jamanetworkopen.2022.54909","article-title":"Circulation of rhinoviruses and\/or enteroviruses in pediatric patients with acute respiratory illness before and during the COVID-19 pandemic in the US","volume":"6","author":"Rankin","year":"2023","journal-title":"JAMA Netw Open"},{"key":"B173","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1164\/rccm.200802-309OC","article-title":"Wheezing rhinovirus illnesses in early life predict asthma development in high-risk children","volume":"178","author":"Jackson","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"B174","doi-asserted-by":"publisher","first-page":"1987","DOI":"10.1016\/S0149-2918(02)80093-5","article-title":"The seasonality of rhinovirus infections and its implications for clinical recognition","volume":"24","author":"Monto","year":"2002","journal-title":"Clin Ther"},{"key":"B175","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1073\/pnas.1411030112","article-title":"Temperature-dependent innate defense against the common cold virus limits viral replication at warm temperature in mouse airway cells","volume":"112","author":"Foxman","year":"2015","journal-title":"Proc Natl Acad Sci USA"},{"key":"B176","doi-asserted-by":"publisher","first-page":"414","DOI":"10.4168\/aair.2025.17.4.414","article-title":"Clinical significance of rhinoviruses and progress toward vaccination","volume":"17","author":"Lee","year":"2025","journal-title":"Allergy Asthma Immunol Res"},{"key":"B177","doi-asserted-by":"publisher","first-page":"e88981","DOI":"10.1371\/journal.pone.0088981","article-title":"Population structure and evolution of rhinoviruses","volume":"9","author":"Waman","year":"2014","journal-title":"PLoS One"},{"key":"B178","doi-asserted-by":"publisher","first-page":"D770","DOI":"10.1093\/nar\/gkad937","article-title":"RVdb: a comprehensive resource and analysis platform for rhinovirus research","volume":"52","author":"Zhao","year":"2024","journal-title":"Nucleic Acids Res"},{"key":"B179","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1093\/oxfordjournals.aje.a121076","article-title":"Evidence for protective effect of an inactivated rhinovirus vaccine administered by the nasal route","volume":"90","author":"Perkins","year":"1969","journal-title":"Am J Epidemiol"},{"key":"B180","doi-asserted-by":"publisher","first-page":"12838","DOI":"10.1038\/ncomms12838","article-title":"A polyvalent inactivated rhinovirus vaccine is broadly immunogenic in rhesus macaques","volume":"7","author":"Lee","year":"2016","journal-title":"Nat Commun"},{"key":"B181","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1183\/09031936.00149109","article-title":"Antibodies induced with recombinant VP1 from human rhinovirus exhibit cross-neutralisation","volume":"37","author":"Edlmayr","year":"2011","journal-title":"Eur Respir J"},{"key":"B182","doi-asserted-by":"publisher","first-page":"521","DOI":"10.3390\/v11060521","article-title":"Impact of rhinovirus infections in children","volume":"11","author":"Vandini","year":"2019","journal-title":"Viruses"},{"key":"B183","doi-asserted-by":"publisher","first-page":"7993","DOI":"10.1073\/pnas.88.18.7993","article-title":"Identification of monoclonal antibody epitopes and critical residues for rhinovirus binding in domain 1 of intercellular adhesion molecule 1","volume":"88","author":"McClelland","year":"1991","journal-title":"Proc Natl Acad Sci USA"},{"key":"B184","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1038\/89098","article-title":"A newly discovered human pneumovirus isolated from young children with respiratory tract disease","volume":"7","author":"van Den Hoogen","year":"2001","journal-title":"Nat Med"},{"key":"B185","doi-asserted-by":"publisher","first-page":"e340","DOI":"10.1016\/S2666-5247(22)00386-X","article-title":"Wastewater concentrations of human influenza, metapneumovirus, parainfluenza, respiratory syncytial virus, rhinovirus, and seasonal coronavirus nucleic-acids during the COVID-19 pandemic: a surveillance study","volume":"4","author":"Boehm","year":"2023","journal-title":"Lancet Microbe"},{"key":"B186","doi-asserted-by":"publisher","first-page":"1557880","DOI":"10.3389\/fcimb.2025.1557880","article-title":"Receptors and host factors: key players in human metapneumovirus infection","volume":"15","author":"Dong","year":"2025","journal-title":"Front Cell Infect Microbiol"},{"key":"B187","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1038\/s41586-019-1759-1","article-title":"Structure of the human metapneumovirus polymerase phosphoprotein complex","volume":"577","author":"Pan","year":"2020","journal-title":"Nature"},{"key":"B188","doi-asserted-by":"publisher","first-page":"eabj7843","DOI":"10.1126\/scitranslmed.abj7843","article-title":"Fatal enhanced respiratory syncytial virus disease in toddlers","volume":"13","author":"Polack","year":"2021","journal-title":"Sci Transl Med"},{"key":"B189","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1099\/vir.0.2008\/002022-0","article-title":"Generation of temperature-sensitive human metapneumovirus strains that provide protective immunity in hamsters","volume":"89","author":"Herfst","year":"2008","journal-title":"J Gen Virol"},{"key":"B190","doi-asserted-by":"publisher","first-page":"4224","DOI":"10.1016\/j.vaccine.2008.05.052","article-title":"Immunogenicity and efficacy of two candidate human metapneumovirus vaccines in cynomolgus macaques","volume":"26","author":"Herfst","year":"2008","journal-title":"Vaccine"},{"key":"B191","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.antiviral.2010.07.001","article-title":"Prophylactic and therapeutic benefits of a monoclonal antibody against the fusion protein of human metapneumovirus in a mouse model","volume":"88","author":"Hamelin","year":"2010","journal-title":"Antiviral Res"},{"key":"B192","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1177\/135965350801300104","article-title":"The prophylactic administration of a monoclonal antibody against human metapneumovirus attenuates viral disease and airways hyperresponsiveness in mice","volume":"13","author":"Hamelin","year":"2008","journal-title":"Antivir Ther"},{"key":"B193","doi-asserted-by":"publisher","first-page":"e00342-19","DOI":"10.1128\/JVI.00342-19","article-title":"A potent neutralizing site III-specific human antibody neutralizes human metapneumovirus in vivo","volume":"93","author":"Bar-Peled","year":"2019","journal-title":"J Virol"},{"key":"B194","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1093\/infdis\/jiu307","article-title":"A broadly neutralizing human monoclonal antibody exhibits in vivo efficacy against both human metapneumovirus and respiratory syncytial virus","volume":"211","author":"Schuster","year":"2015","journal-title":"J Infect Dis"},{"key":"B195","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1186\/s12890-025-03587-z","article-title":"Prevalence of respiratory viruses in children with respiratory tract infections during the COVID-19 pandemic era: a systematic review and meta-analysis","volume":"25","author":"Khales","year":"2025","journal-title":"BMC Pulm Med"},{"key":"B196","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1093\/jpids\/piu047","article-title":"Estimates of parainfluenza virus-associated hospitalizations and cost among children aged less than 5 years in the United States, 1998\u20132010","volume":"5","author":"Abedi","year":"2016","journal-title":"J Pediatric Infect Dis Soc."},{"key":"B197","doi-asserted-by":"publisher","first-page":"e1077","DOI":"10.1016\/S2214-109X(21)00218-7","article-title":"Global burden of acute lower respiratory infection associated with human parainfluenza virus in children younger than 5 years for 2018: a systematic review and meta-analysis","volume":"9","author":"Wang","year":"2021","journal-title":"Lancet Glob Health"},{"key":"B198","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1093\/oxfordjournals.aje.a120957","article-title":"Field evaluation of A respiratory syncytial virus vaccine and A trivalent parainfluenza virus vaccine in A pediatric population","volume":"89","author":"Chin","year":"1969","journal-title":"Am J Epidemiol"},{"key":"B199","doi-asserted-by":"publisher","first-page":"e143","DOI":"10.1093\/jpids\/piu104","article-title":"Evaluation of a live-attenuated human parainfluenza type 1 vaccine in adults and children","volume":"4","author":"Karron","year":"2015","journal-title":"J Pediatric Infect Dis Soc"},{"key":"B200","doi-asserted-by":"publisher","first-page":"430","DOI":"10.3390\/vaccines13040430","article-title":"Intranasal sendai virus vaccination of seropositive children 1 to 2 years of age in a phase I clinical trial boosts immune responses toward human parainfluenza virus type 1","volume":"13","author":"Adderson","year":"2025","journal-title":"Vaccines (Basel)"},{"key":"B201","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1093\/infdis\/172.6.1445","article-title":"A live human parainfluenza type 3 virus vaccine is attenuated and immunogenic in healthy infants and children","volume":"172","author":"Karron","year":"1995","journal-title":"J Infect Dis"},{"key":"B202","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1586\/ers.11.32","article-title":"Progress in the development of human parainfluenza virus vaccines","volume":"5","author":"Schmidt","year":"2011","journal-title":"Expert Rev Respir Med"},{"key":"B203","doi-asserted-by":"publisher","first-page":"1912884","DOI":"10.1080\/19420862.2021.1912884","article-title":"Protective antibodies against human parainfluenza virus type 3 infection","volume":"13","author":"Boonyaratanakornkit","year":"2021","journal-title":"MAbs"},{"key":"B204","author":"Lee","year":"2024"},{"key":"B205","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1007\/s40588-016-0040-8","article-title":"Paramyxovirus glycoproteins and the membrane fusion process","volume":"3","author":"Aguilar","year":"2016","journal-title":"Curr Clin Microbiol Rep"},{"key":"B206","doi-asserted-by":"publisher","first-page":"1710895","DOI":"10.3389\/fimmu.2026.1710895","article-title":"RSV Vaccine development: advances and fusion protein-focused strategies","volume":"17","author":"Xu","year":"2026","journal-title":"Front Immunol"},{"key":"B207","doi-asserted-by":"publisher","first-page":"1818721","DOI":"10.3389\/fimmu.2026.1818721","article-title":"Determinants of success and failure of antibody-based strategies against respiratory viruses: insights from RSV and SARS-CoV-2","volume":"17","author":"Guo","year":"2026","journal-title":"Front Immunol"},{"key":"B208","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.3390\/pathogens11121521","article-title":"Strategies of influenza A virus to ensure the translation of viral mRNAs","volume":"11","author":"Li","year":"2022","journal-title":"Pathogens"},{"key":"B209","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.3390\/cells10061424","article-title":"How SARS-CoV-2 and other viruses build an invasion route to hijack the host nucleocytoplasmic trafficking system","volume":"10","author":"Sajidah","year":"2021","journal-title":"Cells"},{"key":"B210","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.smim.2015.03.005","article-title":"Early IFN type I response: learning from microbial evasion strategies","volume":"27","author":"Coccia","year":"2015","journal-title":"Semin Immunol"},{"key":"B211","doi-asserted-by":"publisher","first-page":"7365","DOI":"10.3390\/ijms23137365","article-title":"Comparison of cell fusions induced by influenza virus and SARS-CoV-2","volume":"23","author":"Zhang","year":"2022","journal-title":"Int J Mol Sci"}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2026.1864969\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T05:39:22Z","timestamp":1785389962000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2026.1864969\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,30]]},"references-count":211,"alternative-id":["10.3389\/fped.2026.1864969"],"URL":"https:\/\/doi.org\/10.3389\/fped.2026.1864969","relation":{},"ISSN":["2296-2360"],"issn-type":[{"value":"2296-2360","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,30]]},"article-number":"1864969"}}